Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. (APLS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APLS · as of Jun 8, 2026
Key Statistics
Explore Apellis Pharmaceuticals, Inc. Data
apls stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 25 · Buy rate: 72.0%
The APLS analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $33.40, representing -18.60% downside from the current price of $41.03.
Competitors & Peers
apls competitorsAPLS
ADPT
AGIO
BEAM
CDTX
CPRXStock Performance
Full HistoryAbout Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complem…
what is apellis pharmaceuticals, inc. · apls stock overview · apellis pharmaceuticals, inc. company profile · who is apellis pharmaceuticals, inc. ceo · apls NASDAQ · apellis pharmaceuticals, inc. headquarters · apellis pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Apellis Pharmaceuticals, Inc. (APLS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 9, 2017. As of the latest trading session, APLS stock price is $41.03, with a market capitalization of $5.3B. The stock has returned +111.60% over the past 12 months and +63.34% year-to-date.
According to 25 Wall Street analysts, the consensus rating for Apellis Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $33.40. In fiscal year 2025, Apellis Pharmaceuticals, Inc. reported revenue of $1.0B and net income of $22.4M. For detailed data — including Apellis Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Apellis Pharmaceuticals, Inc. (APLS) stock price is $41.03. The stock is traded on NASDAQ under the ticker symbol APLS. The 52-week range is $16.61 – $41.14.